U.S. Hospitality Stock News

In early April 2026, Penguin Solutions, Inc. reported second-quarter results showing lower revenue of US$343 million year on year but sharply higher net income of US$37.45 million and raised its full-year 2026 outlook to target 12% year over year net sales growth (plus or minus 5%) and diluted EPS of US$1.30 (plus or minus US$0.15). The company also filed employee stock ownership plan-related shelf registrations and saw several pre-planned insider stock sales, developments that contrast with...

In recent days, ADMA Biologics has come under scrutiny after a short-seller report alleged channel stuffing around its ASCENIV product, prompting multiple law firms to investigate potential securities law violations and raising questions about the quality of its reported revenues. The developments have also led at least one covering analyst to downgrade the stock, citing concerns over ADMA’s limited public response and growing receivables indicators that may signal pressure on revenue...

Wondering if ConocoPhillips at around US$123.62 offers fair value or if the market is getting ahead of itself? This breakdown helps you frame the price against fundamentals rather than just headlines. The stock has seen a 6.1% decline over the last 7 days, a 1.4% return over 30 days, and a 27.8% return year to date, with a 47.9% return over the last year and 190.4% over 5 years. Recent coverage of ConocoPhillips has focused on its role as a major US energy name and how broader energy market...

Terreno Realty (TRNO) has completed Countyline Corporate Park Phase IV Building 34 in Hialeah, Florida. The 220,000 square foot facility is fully leased and is expected to achieve LEED certification. See our latest analysis for Terreno Realty. These fully leased projects in Miami and Washington, D.C. arrive as Terreno Realty’s share price trades at $65.60, with an 11.15% year to date share price return and a 21.96% 1 year total shareholder return, suggesting building momentum. If this kind of...

In early April 2026, Weis Markets disclosed that it would restate multiple prior-year audited financial statements after discovering overstated inventory and also delay filing its 2025 annual report. The announcement has prompted law firm Bronstein, Gewirtz & Grossman, LLC to investigate potential claims on behalf of Weis Markets shareholders, spotlighting concerns about the company’s accounting controls and financial reporting reliability. We’ll now examine how the restatement of prior-year...

Valaris Limited previously announced that it secured a 1,064-day contract extension with Petrobras for drillship VALARIS DS-4 offshore Brazil, expected to start in November 2027, adding about US$447 million to backlog while slightly reducing the remaining value of the current contract by roughly US$21 million due to a day-rate adjustment. Separately, Halliburton disclosed a collaboration with PETRONAS Suriname and Valaris that links subsurface evaluation, field planning, and digital well...

Critical Metals Corp. reported that 2025 metallurgical test work for its Tanbreez rare earths project in Greenland replicated and improved on 2016 results, delivering higher-grade TREO and HREO concentrates with recovery rates better than 85% using an upgraded magnetic separation flowsheet. This past test program, now moving into pilot plant operations planned for May 2026 with a 150-tonne bulk sample and offtake testing, marks a key step in validating Tanbreez’s processing route and...

Lucid Group resolved a supplier related issue that temporarily disrupted Q1 deliveries of its Gravity SUV. The company reaffirmed its full year production guidance after addressing the supply chain problem. Lucid also unveiled major updates planned for its 2027 Gravity lineup, including new technology and personalization options. For investors watching NasdaqGS:LCID, the update comes against a backdrop of steep share price declines over longer periods, including a 63.5% drop over the past...

In early 2025, Live Oak Bancshares reported strong fundamental improvements, including a roughly 20% increase in revenue and around 70% growth in earnings per share, alongside continued positive analyst coverage. InvestingPro’s prior assessment that the bank was significantly undervalued gained traction as subsequent results helped validate its valuation framework and the company’s improving fundamentals. Next, we’ll examine how this earnings strength and reaffirmed analyst confidence...

Beyond Meat (BYND) has drawn fresh attention after announcing a nationwide rollout of its Beyond Breakfast Sausage line at major retailers. This gives investors a new product launch to weigh alongside the company’s recent financial updates. See our latest analysis for Beyond Meat. The share price has reacted sharply to recent news, with a 1-day share price return of 10.63% and a 7-day return of 11.86%. However, the 1-year total shareholder return of 75.56% and the 5-year total shareholder...

Arcos Dorados Holdings (NYSE:ARCO), the master franchisee for McDonald’s across Latin America and the Caribbean, has drawn investor attention after recent share price gains over the past month and the past three months. See our latest analysis for Arcos Dorados Holdings. Those recent gains build on a 30 day share price return of 11.93% and a year to date share price return of 18.38%, alongside a 1 year total shareholder return of 22.44%. Together, these figures point to strengthening momentum...

Institutional interest and shareholder proposals come into focus Pzena Investment Management’s disclosure of an 11.3% stake in Amdocs (NasdaqGS:DOX), alongside proposals for a higher quarterly dividend and an expanded Employee Share Purchase Plan, has drawn fresh attention to the stock’s current setup for shareholders. See our latest analysis for Amdocs. At a share price of US$64.94, Amdocs has seen a 3.1% 1 day share price return but a 21.6% 90 day share price return decline, while the 1...

In late March 2026, Scholar Rock announced it had resubmitted its Biologics License Application to the FDA for apitegromab in spinal muscular atrophy, incorporating both the Catalent Indiana facility and a second U.S.-based fill-finish site in line with recent agency guidance. This resubmission, following a prior Complete Response Letter tied to manufacturing inspections rather than apitegromab itself, shifts regulatory focus back to the drug’s clinical profile and supply-chain readiness...

Earlier this month, Dover Corporation entered into a new US$1,500 million five-year unsecured revolving credit facility and, through Advansor, launched the SteelXL Heat Pump, a high-capacity CO₂ system aimed at food processing, district heating, and large commercial buildings. The SteelXL Heat Pump’s industrial-scale capacity and regulatory-friendly CO₂ technology highlight Dover’s push into lower-emission thermal solutions for large HVAC and process-heating users. We’ll now examine how this...

In the past few days, Raymond James analyst Tiago Fauth renewed coverage on Ionis Pharmaceuticals with an Outperform rating, highlighting an improved outlook anchored by the RNA-based drug Tryngolza for severe hypertriglyceridemia. This latest endorsement underscores how Tryngolza, already central to Ionis’ expansion into larger patient groups, is increasingly viewed as a key pillar of its RNA medicines portfolio despite ongoing profitability and insider selling concerns. Now we’ll examine...

Ecovyst recently reported quarterly earnings that came in ahead of analyst expectations and issued full-year 2026 EPS guidance in the US$0.45–US$0.65 range, prompting several brokerages to reaffirm or upgrade their views on the company’s outlook. This combination of an earnings beat and clearer profit guidance has sharpened the focus on how Ecovyst’s fundamentals align with assessments that its shares may be trading at a premium to intrinsic value. We’ll now explore how Ecovyst’s...

Delek Logistics Partners recently secured a US$1.30 billion revolving credit facility led by Truist Bank, providing refinancing capacity, an accordion feature for additional borrowing, and funds for acquisitions, capital projects, and general corporate purposes that are intended to bolster its balance sheet and liquidity. This expanded credit access meaningfully alters Delek Logistics Partners’ financial toolkit, potentially affecting how it funds growth projects, manages leverage, and...

Oruka Therapeutics, Inc. previously filed an omnibus shelf registration statement of up to US$1 billion, covering common stock, preferred stock, depositary shares, and warrants, providing a framework for potential future capital raising. This broad shelf capacity gives Oruka considerable flexibility in how and when it may access the capital markets to support its pipeline and operations. Next, we will examine how this expansive US$1 billion shelf registration could influence Oruka...

Why Honeywell’s Dangote Refinery Deal Matters for HON Stock Honeywell International (HON) is back in focus after expanding its work with Nigeria’s Dangote Petroleum Refinery. The company will supply connected performance monitoring, digital process technologies, and operator training simulators across key processing units. See our latest analysis for Honeywell International. Recent news around Dangote comes during a busy period for Honeywell, with the share price at US$233.64 and a 90 day...

VeriSign (VRSN) is back in focus after recent share price moves, with the stock last closing at US$271.44. Investors are weighing that price against the company’s earnings profile and recent return figures. See our latest analysis for VeriSign. The recent 4.49% 1 day share price return builds on a 13.76% 30 day share price return and 12.85% year to date share price return, while the 5 year total shareholder return of 32.60% shows more moderate longer term compounding. If this sort of move...

Recent interest in Lightwave Logic (LWLG) centers on its electro optic polymer modulators being added to the GDSFactory design kit, as well as a new development agreement with Tower Semiconductor, both tied to data center and AI applications. See our latest analysis for Lightwave Logic. The recent design kit integration and Tower Semiconductor agreement sit alongside a sharp upswing in the share price, with a 30 day share price return of 49.67% and a 90 day gain of 151.99%. The one year total...

In April 2026, Natera highlighted interim futility analysis from Allogene Therapeutics’ registrational ALPHA3 trial, where its off‑the‑shelf anti‑CD19 CAR T candidate cema‑cel achieved molecular residual disease clearance in a majority of treated large B‑cell lymphoma patients and showed deep reductions in plasma ctDNA compared with observation alone. Because ALPHA3 is the first MRD‑guided randomized trial in this lymphoma setting, these early data not only support cema‑cel’s potential role...

TFS Financial (TFSL) is in focus after announcing that longtime executive Meredith S. Weil will retire as Chief Financial Officer and Board member in January 2027, with finance leader James E. LaRocca expected to be her successor. See our latest analysis for TFS Financial. The CFO transition news lands as the 30 day share price return of 9.25% and year to date share price return of 8.77% point to improving momentum, while the 1 year total shareholder return of 34.44% highlights stronger long...

Event context and recent share performance PDF Solutions (PDFS) has drawn attention after a recent move in its share price, with the stock last closing at US$40.66 and showing positive returns over the past week and month. Investors are also weighing the longer term picture, including a total 1 year return above 100% alongside relatively flat 3 year performance, as they reassess expectations for this semiconductor software and services provider. See our latest analysis for PDF Solutions. The...